➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: October 25, 2021

DrugPatentWatch Database Preview

Triamcinolone acetonide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic drug sources for triamcinolone acetonide and what is the scope of patent protection?

Triamcinolone acetonide is the generic ingredient in twenty-six branded drugs marketed by Abbvie, Sanofi Aventis Us, Astellas, Ivax Pharms, Delcor Asset Corp, Teva, Solvay, Actavis Mid Atlantic, Alkem Labs Ltd, Alpharma Us Pharms, Ambix, Cosette, Fougera Pharms, Glenmark Pharms Ltd, Lupin, Macleods Pharms Ltd, Micro Labs, Morton Grove, Mylan, Padagis Us, Pharmaderm, Pharmafair, Strides Pharma, Taro, Taro Pharm Inds Ltd, Teligent, Topiderm, Crown Labs, Savage Labs, Flexion Theraps Inc, Apothecon, Amneal, Parnell, Sandoz Inc, Teva Pharms Usa, Watson Labs, Allergan, Novartis, Akorn, Quagen, Wockhardt Bio Ag, Cintex Svcs, Encube, Glenmark Pharms, Novel Labs Inc, Padagis Israel, Cmp Pharma Inc, Lyne, Lupin Atlantis, Perrigo, Sun Pharm Inds Inc, and Rising, and is included in one hundred and thirty-one NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Triamcinolone acetonide has seventy-five patent family members in twenty-six countries.

There are fifty-one drug master file entries for triamcinolone acetonide. Sixty-five suppliers are listed for this compound.

Summary for triamcinolone acetonide

International Patents:	75
US Patents:	4
Tradenames:	26
Applicants:	52
NDAs:	131
Drug Master File Entries:	51
Finished Product Suppliers / Packagers:	65
Raw Ingredient (Bulk) Api Vendors:	72
Clinical Trials:	195
Patent Applications:	7,231
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for triamcinolone acetonide
Drug Sales Revenues:	Drug sales revenues for triamcinolone acetonide
What excipients (inactive ingredients) are in triamcinolone acetonide?	triamcinolone acetonide excipients list
DailyMed Link:	triamcinolone acetonide at DailyMed

See drug prices for triamcinolone acetonide

Drug Sales Revenue Trends for triamcinolone acetonide

See drug sales revenues for triamcinolone acetonide

Recent Clinical Trials for triamcinolone acetonide

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Duke University	Phase 2
Sorrento Therapeutics, Inc.	Phase 2
Dow University of Health Sciences	Early Phase 1

See all triamcinolone acetonide clinical trials

Pharmacology for triamcinolone acetonide

Drug Class	Corticosteroid
Mechanism of Action	Corticosteroid Hormone Receptor Agonists

Medical Subject Heading (MeSH) Categories for triamcinolone acetonide

Anti-Inflammatory Agents
Glucocorticoids
Immunosuppressive Agents

US Patents and Regulatory Information for triamcinolone acetonide

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alpharma Us Pharms	TRIAMCINOLONE ACETONIDE	triamcinolone acetonide	CREAM;TOPICAL	087797-001	Jun 7, 1982		DISCN	No	No	⤷ Try it Free	⤷ Try it Free				⤷ Try it Free
Ivax Pharms	FLUTEX	triamcinolone acetonide	OINTMENT;TOPICAL	087375-001	Nov 1, 1988		DISCN	No	No	⤷ Try it Free	⤷ Try it Free				⤷ Try it Free
Ivax Pharms	TRIATEX	triamcinolone acetonide	CREAM;TOPICAL	087428-001	Nov 1, 1988		DISCN	No	No	⤷ Try it Free	⤷ Try it Free				⤷ Try it Free
Taro	TRIAMCINOLONE ACETONIDE	triamcinolone acetonide	PASTE;DENTAL	070730-001	Oct 1, 1986	AT	RX	No	Yes	⤷ Try it Free	⤷ Try it Free				⤷ Try it Free
Novartis	TRIESENCE	triamcinolone acetonide	INJECTABLE;INTRAVITREAL	022048-001	Nov 29, 2007		RX	Yes	Yes	⤷ Try it Free	⤷ Try it Free				⤷ Try it Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for triamcinolone acetonide

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbvie	AZMACORT	triamcinolone acetonide	AEROSOL, METERED;INHALATION	018117-001	Apr 23, 1982	⤷ Try it Free	⤷ Try it Free
Sanofi Aventis Us	NASACORT ALLERGY 24 HOUR	triamcinolone acetonide	SPRAY, METERED;NASAL	020468-002	Oct 11, 2013	⤷ Try it Free	⤷ Try it Free
Novartis	TRIESENCE	triamcinolone acetonide	INJECTABLE;INTRAVITREAL	022048-001	Nov 29, 2007	⤷ Try it Free	⤷ Try it Free
Sanofi Aventis Us	NASACORT	triamcinolone acetonide	AEROSOL, METERED;NASAL	019798-001	Jul 11, 1991	⤷ Try it Free	⤷ Try it Free
Sanofi Aventis Us	NASACORT ALLERGY 24 HOUR	triamcinolone acetonide	SPRAY, METERED;NASAL	020468-002	Oct 11, 2013	⤷ Try it Free	⤷ Try it Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for triamcinolone acetonide

Subscribe to access the full database, or Try it Free
Country	Patent Number	Estimated Expiration
Russian Federation	2481842	⤷ Try it Free
Taiwan	I548412	⤷ Try it Free
European Patent Office	3701941	⤷ Try it Free
European Patent Office	3281631	⤷ Try it Free
Brazil	PI0909630	⤷ Try it Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.